Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.42 → 0.42 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CWD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful note conversion program execution | Its note conversion program may improve capital structure. | Intact | Note conversion program fails or is materially delayed | Program launched Sep 2026 vs End 2026 target Company launched a note exchange program in September 2026, allowing holders to convert notes into subordinated amortizing notes. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making real estate development and platform story, rather than a proven durable compounder. The thesis is in a watch state: management has shown some project and product execution, but recent performance is weak and management execution is volatile.
The evidence labels CWD cheap versus peers, but valuation confidence is low and the expectations gap is negative. That suggests the low relative valuation may reflect real business risks, including ongoing losses and weak results, rather than a clear mismatch between price and prospects.
Near term, the risk of another earnings miss is elevated, and a guidance cut would add pressure to the business outlook. Across the supplied quarters, revenue declined from $4.294 million to $4.194 million, while management kept its 2026 revenue guidance unchanged. Groundbreaking and financing milestones, along with the first fund tokenization, show execution, but their financial contribution remains limited so far.
Over the next few quarters, the key test is whether the project pipeline and Hyatt Studios platform convert into sustained revenue growth and profitability. The thesis also depends on guidance and execution, the contribution from tokenization, and sector conditions: continued strength at financial-sector peers could support momentum, while rate cuts or a guidance reduction are stated risks.
For the 1-to-3-year view, CWD remains a high-risk watch case with early signs of project progress but little evidence yet of improved financial conversion. The long-term thesis hinges on stronger results and reliable execution, while the low-confidence valuation evidence offers limited reassurance. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is managing executive transitions with a new CFO. |
| Under Pressure |
| additional CFO or key director departures occur within next 12 months |
1 CFO departure vs 0 allowed CFO transition announced June 2026; Jade Leung resigned for personal reasons. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $20 million in FY26 | CaliberCos aims to stabilize revenue near $20 million in 2026. | Under Pressure | revenue falls below $18 million in FY26 | Revenue: $4.194M FY2026-Q2; GAAP. Published target: ~$20 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 20264,194,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.42 → $0.42 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-25 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-26 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-27 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-28 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-29 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-30 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-07-31 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-01 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-02 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-03 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-04 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-05 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-06 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-07 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-08 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-09 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-10 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-11 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-12 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-13 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-14 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-15 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-16 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-17 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-18 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-19 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-20 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-21 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-22 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-23 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-24 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-25 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-26 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-27 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-28 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-29 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-30 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-08-31 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-01 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-02 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-03 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-04 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-05 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-06 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-07 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-08 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-09 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-10 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-11 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-12 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-13 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-14 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-15 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-16 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-17 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-18 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-19 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-20 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-21 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-22 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-23 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-24 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-25 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-26 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-27 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-28 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-29 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-09-30 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-01 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-02 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-03 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-04 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-05 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-06 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-07 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-08 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-09 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-10 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-11 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-12 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-13 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-14 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-15 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-16 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-17 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-18 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-19 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-20 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-21 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-22 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-23 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-24 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-25 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-26 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-27 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-28 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-29 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-30 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-10-31 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-11-01 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-11-02 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-11-03 | $0.42 | $23,151,000 | 1 / 1 |
| 2026-11-04 | $0.42 | $23,151,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.